4th Quarter - Report
NVG, LLC for ALEXION PHARMACEUTICALS
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Intellectual property and potential changes to the patent system, generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE | — |
Health Issues HCR
FDA - rare and orphan disease issues; H.R. 34, 21st Century CURES Act, provisions of Tsunami Warning, Education & Research Act of 2015; Prescription drug coverage and payment policies; Medical innovation issues; H.R. 1537, Advancing Hope Act of 2015; S. 1878, Advancing Hope Act of 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA GERMAN FOSTER | — |
| PATRICIA GRIFFIN | — |
| ANDREA LARUE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.